Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × bexmarilimab × Gastrointestinal × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 Genitourinary 1 Gastrointestinal 1

Conditions

Colonic Neoplasms 1 Carcinoma, Renal Cell 1

Interventions

Fluorouracil 45 Oxaliplatin 43 Leucovorin 36 Gemcitabine 35 Capecitabine 30 Bevacizumab 24 Irinotecan 22 Radiotherapy 17 Cisplatin 17 pembrolizumab 16 Radiosurgery 15 Nivolumab 14 Cetuximab 14 Taxes 12 Sorafenib 12 Biopsy 12 Surgical Procedures, Operative 11 Paclitaxel 11 lenvatinib 9 Radiation 9 Cyclophosphamide 8 spartalizumab 7 fludarabine 7 durvalumab 7 atezolizumab 7 aflibercept 7 S 1 (combination) 7 Magnetic Resonance Spectroscopy 7 Folfox protocol 7 Drug Therapy 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05104905 2022-05-11

RENACOL

Faron Pharmaceuticals Ltd

Phase 1/2 Withdrawn

GastrointestinalGenitourinary

Carcinoma, Renal Cell, Colonic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡